HC Wainwright Is Bullish On DICE Therapeutics – Read Why
H.C. Wainwright analyst Emily Bodnar initiated coverage on DICE Therapeutics Inc (NASDAQ:DICE) with a Buy rating and a price target of $40 (150%…
HC Wainwright Initiates Coverage On This Nanocrystals Stock
H.C. Wainwright initiated coverage on Clene Inc (NASDAQ:CLNN) with a Buy rating and a $16 price target. Clene is focused on the…
Nestle Bets €40M On Enterome’s Preclinical Food Allergy, IBD Hopeful
France-based Enterome signed a strategic R&D collaboration and license agreement with Nestlé SA’s (OTC:NSRGF) Health Science, targeting food allergies and inflammatory bowel disease…
HC Wainwright Downgrades Angion Biomedica
Last month, Angion Biomedica Corp (NASDAQ:ANGN) discontinued the JUNIPER Phase 2 dose-finding trial of ANG-3070 in primary proteinuric kidney diseases, specifically focal…
SVB Leerink Picks This Well-Positioned NK Cell-Focused Stock, Sees 117% Upside
SVB Leerink initiated coverage on Nkarta Inc (NASDAQ:NKTX) with an Outperform rating and a price target of $30 (117% implied upside). The…
WHO, UNICEF Sound Alarm As Pandemic Leads Largest Fall In Kids Vaccinations In 30 Years
According to the United Nations Children’s Fund (UNICEF) and the World Health Organization (WHO), approximately 25 million children worldwide missed routine…
AbbVie To Submit European Application For Epcoritamab In Lymphoma Setting Later In 2022
Genmab A/S (NASDAQ:GMAB) has announced that AbbVie Inc (NASDAQ:ABBV) will submit a conditional marketing authorization application with the European Medicines Agency…
Algernon Posts Mixed Bag Results From Mid Stage Chronic Cough Study
Algernon Pharmaceuticals Inc (OTC:AGNPF) has announced topline data showing that it has met the co-primary endpoint in its Phase 2 proof…
PMV Pharma, Merck Ink Clinical Trial Collaboration For Combination Study In Solid Tumors
PMV Pharmaceuticals Inc (NASDAQ:PMVP) has entered into a clinical trial collaboration and supply agreement with Merck & Co Inc (NYSE:MRK) to evaluate PC14586…
‘New data might have led to a different result for Amarin fish oil drug, FDA panelists say’ -STAT News
https://www.statnews.com/2022/07/18/new-data-might-have-led-to-a-different-result-for-amarin-fish-oil-drug-fda-panelists-say/